No images? Click here An invitation to contributeCDI actively invites contributions relating to the occurrence, surveillance, treatment and prevention of communicable disease within Australia. Submissions on all aspects of this topic are considered. The journal currently has a particular interest in original manuscripts from public health units across all jurisdictions of Australia, exploring lessons learned as a result of implementation of public health measures during the COVID-19 pandemic. All unsolicited submissions considered for publication are subject to peer review. For all submissions, please consult our Instructions to Authors for submission guidelines and other pertinent information. Submissions (and queries) can be directed to the Editor at cdi.editor@health.gov.au Latest articlesLetter to the EditorUpskilling the public health workforce in communicable disease control || Original articlesLegionella pneumophila serogroup 1 infection associated with the use of an apartment building spa pool || https://doi.org/10.33321/cdi.2022.46.82 || Published online: 15/12/2022 Undetected serovars: leptospirosis cases in the Cairns region during the 2021 wet season || https://doi.org/10.33321/cdi.2022.46.70 || Published online: 17/11/2022 Short reportsKebabs with a side of Salmonella: Two outbreaks of Salmonella linked to kebab shops in Canberra, ACT || https://doi.org/10.33321/cdi.2022.46.84 || Published online: 15/12/2022 Quarterly reportsMeningococcal Surveillance Australia Reporting period 1 April to 30 June 2022 || https://doi.org/10.33321/cdi.2022.46.81 || Published online: 15/12/2022 Annual reportsAustralian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome Program (ASSOP) Bloodstream Annual Report 2021 || https://doi.org/10.33321/cdi.2022.46.76 || Published online: 15/12/2022 Australian Rotavirus Surveillance Program: Annual Report, 2021 Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Surveillance Outcome Program (AESOP) - Bloodstream Infection Annual Report 2021 || https://doi.org/10.33321/cdi.2022.46.77 || Published online: 17/11/2022 Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) - Bloodstream Infection Annual Report 2021 || https://doi.org/10.33321/cdi.2022.46.78 || Published online: 17/11/2022 Policy and guidelinesConsensus statement on the use of a four-month treatment regimen for drug susceptible tuberculosis in children (< 10 years of age) with uncomplicated disease || https://doi.org/10.33321/cdi.2022.46.85 || Published online: 15/12/2022 CDI is a peer-reviewed open-access journal which does not carry page charges. It is listed on MEDLINE, indexed in PubMed, and available full-text on the Australian Government Department of Health and Aged Care website as well as on the Global Health database (CABI) and the Elsevier services EMBASE and Scopus. Communicable Diseases IntelligenceEditor: Noel Lally Editorial Advisory Board:
ISSN: 2209-6051 (Online) Coronavirus disease (COVID-19) epidemiological reportsFor CDI's coronavirus disease (COVID-19) epidemiological reports within Australia, please refer to the Epidemiological reports page. It includes data on notified Australian cases, the international situation and the current understanding of severity, transmission and spread of the infection. CDI welcomes expressions of interest from potential peer reviewers.If you would like to register on CDI's reviewer database please contact cdi.editor@health.gov.auv.au DisclaimerOpinions expressed in Communicable Diseases Intelligence are those of the authors and not necessarily those of the Australian Government Department of Health and Aged Care or the Communicable Diseases Network Australia. Data may be subject to revision. |